1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Transoral robotic surgery in the management of head and neck squamous cell cancer with unknown primary
- Association between human papillomavirus status and health-related quality of life in oropharyngeal and oral cavity cancer survivors
- Swedish national multicenter study on head and neck cancer of unknown primary : Prognostic factors and impact of treatment on survival
- 2018
-
Rules of engagement - Regulation of complement response in tissue
Abu-Humaidan, Anas Haider LU
(2018)
In Lund University, Faculty of Medicine Doctoral Dissertation Series
2018(91).
Mark
-
Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils.
Abolhalaj, Milad LU ; Askmyr, David LU ; Sakellariou, Christina LU
; Lundberg, Kristina
LU
; Greiff, Lennart
LU
and Lindstedt, Malin
LU
(2018)
In Scientific Reports
8(8030).
Mark
- 2017
-
Dysphagia - Results from multivariable predictive modelling on aspiration from a subset of the ARTSCAN trial
Söderström, Karin ; Nilsson, Per LU
; Laurell, Göran
; Zackrisson, Björn
and Jäghagen, Eva Levring
(2017)
In Radiotherapy and Oncology
122(2).
p.192-199
Mark
- 2015
- PET in the evaluation of head and neck cancer treatment - management of the neck
- 2014
-
Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up
Ottosson, Sandra ; Lindblom, Ulrika LU ; Wahlberg, Peter LU ; Nilsson, Per LU
; Kjellén, Elisabeth
LU
; Zackrisson, Bjorn
; Jaghagen, Eva Levring
and Laurell, Goran
(2014)
In Supportive Care in Cancer
22(9).
p.2361-2369
Mark
- 2013
-
Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3
Ekblad, Lars LU
; Lindgren, Gustaf
LU
; Persson, Emma
; Kjellén, Elisabeth
LU
and Wennerberg, Johan
LU
(2013)
In BMC Cancer
13.
Mark
- 2012
- Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts